Compositions and methods for the treatment of parkinson's disease
CA 2416233 A1 · Owner: Alpha Research Group, Llc · Inventors: Nelson, Jodi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides compositions and methods for increasing cellular respiration of melanized catecholamine neurons and methods for alleviating , symptoms or stopping appearance and/or progression of symptoms of Parkinson's Disease, and methods for preventing symptoms of on-off syndrome associated with treatment with dopamine or a dopamine agonist of a patient suffering symptoms of a disease selected from the group consisting of idiopathic and atypical Parkinson's disease, conditions characterized by nigrostriatal degeneration and multiple system atrophy said methods comprising , administering to said patient an effective amount of a neuromelanin-binding composition having a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.